Loading clinical trials...

Effects of Schema Therapy vs. Cognitive Behavioral Therapy vs. Individual Supportive Therapy | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNANCT03287362

Effects of Schema Therapy vs. Cognitive Behavioral Therapy vs. Individual Supportive Therapy

The OPTIMA-Study: Optimized Treatment Identification at the Max Planck Institute of Psychiatry: An outline Depressive disorders represent one of the most frequent diseases worldwide. Schema therapy, ...

Lead sponsor: Max-Planck-Institute of Psychiatry•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITINGPhase 3

Ketamine Augmentation of ECT in Treatment-Resistant Depression

NCT07088380 · Major Depressive Disorder, Treatment Resistant Depression

RECRUITINGPhase 2

Lemborexant for the Treatment of Residual Insomnia in Major Depressive Disorder (MDD)

NCT06843187 · Major Depressive Disorder(MDD), Insomnia Comorbid to Psychiatric Disorder

RECRUITINGPhase 3

"A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder"

NCT06564818 · Major Depressive Disorder

RECRUITINGNA

RESISTance Exercise for Depression Trial

NCT06110897 · Major Depressive Disorder

RECRUITINGPhase 1/2

Neural Response to Inflammatory Challenge in Major Depressive Disorder

NCT04751331 · Major Depressive Disorder

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: May 13, 2025Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment300

Start dateSep 2017

Last updatedMay 13, 2025

Condition

Major Depressive Disorder

Locations shown

Max Planck Institute of Psychiatry

Munich

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 13, 2025Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions